20:17 · 10 āļāļļāļĄāļ āļēāļžāļąāļ™āļ˜āđŒ 2025

McDonald's results below forecasts 📊

McDonald's (MCD.US) reported weaker-than-expected results for Q4. Both revenue growth and adjusted earnings per share came in below forecasts. Nevertheless, the stock is seeing gains in pre-market trading.

McDonald's revenue for Q4 amounted to $6.39 billion, representing a year-over-year decline of approximately 0.3% and falling $50 million short of consensus estimates. Operating profit showed a slight year-over-year improvement, reaching $2.87 billion.

The company has adopted an aggressive promotional strategy aimed at attracting more customers. In the U.S. market, this approach appears to be having a positive impact, as McDonald's reported an increase in customer traffic at existing restaurants. However, total comparable sales in the country declined by 1.4% (versus an expected decline of 0.4%). Thanks to stronger-than-expected comparable sales growth at franchised international locations (up 4.1% YoY), overall comparable sales increased by 0.4% in Q4.

Investors are currently showing some confidence in the company despite the overall negative tone of the results. While McDonald's is struggling with revenue growth dynamics, the market's initial reaction suggests optimism that attracting new customers through promotions could become a stronger trend, ultimately helping the company return to improving its financial performance.McDonald's pre-market trading. Source: xStation 

Q4 2024 RESULTS:

  • Revenue: $6.39 billion, -0.3% YoY (Estimate: $6.45 billion)
  • Operating Profit: $2.87 billion, +2.4% YoY
  • Comparable Sales Growth: +0.4% (Q4 2023: +3.4%, Estimate: -0.93%)
    • U.S. Comparable Sales: -1.4% (Q4 2023: +4.3%, Estimate: -0.41%)
    • International Operated Markets Comparable Sales: +0.1% (Q4 2023: +4.4%, Estimate: -1.14%)
    • International Licensed Markets Comparable Sales: +4.1% (Q4 2023: +0.7%, Estimate: -0.38%)
  • Earnings Per Share (EPS, GAAP): $2.80 ($2.80 in Q4 2023)
  • Adjusted EPS: $2.83 ($2.95 in Q4 2023, Estimate: $2.84)

āđ€āļ›āļīāļ”āļšāļąāļāļŠāļĩāļŸāļĢāļĩ

āđ€āļ›āļīāļ”āļšāļąāļāļŠāļĩāļ‚āļ­āļ‡āļ„āļļāļ“āđ„āļ”āđ‰āļ­āļĒāđˆāļēāļ‡āļĢāļ§āļ”āđ€āļĢāđ‡āļ§āđ‚āļ”āļĒāđ„āļĄāđˆāļ•āđ‰āļ­āļ‡āļœāđˆāļēāļ™āļ‚āļąāđ‰āļ™āļ•āļ­āļ™āļĒāļļāđˆāļ‡āļĒāļēāļ āļāļēāļĢāļāļēāļāđāļĨāļ°āļ–āļ­āļ™āđ€āļ‡āļīāļ™āđ‚āļ”āļĒāđ„āļĄāđˆāļĄāļĩāļ„āđˆāļēāļ˜āļĢāļĢāļĄāđ€āļ™āļĩāļĒāļĄ

āđ€āļ›āļīāļ”āļšāļąāļāļŠāļĩ  āļ”āļēāļ§āļ™āđŒāđ‚āļŦāļĨāļ”āđāļ­āļ› 
17 āļŠāļīāļ‡āļŦāļēāļ„āļĄ 2026, 20:20

Market Wrap: āļŦāļļāđ‰āļ™āļŠāļīāļ›āļĒāļļāđ‚āļĢāļ›āļžāļļāđˆāļ‡āđāļĢāļ‡ āļŦāļĨāļąāļ‡āļœāļĨāļ›āļĢāļ°āļāļ­āļšāļāļēāļĢāļ‚āļ­āļ‡ Anthropic! AstraZeneca āļĢāļ°āļ‡āļąāļšāļāļēāļĢāļ—āļ”āļĨāļ­āļ‡āļĒāļēāļĢāļąāļāļĐāļēāļĄāļ°āđ€āļĢāđ‡āļ‡āļ›āļ­āļ”

14 āļŠāļīāļ‡āļŦāļēāļ„āļĄ 2026, 21:20

Market Wrap: āļŦāļļāđ‰āļ™āļ‹āļ­āļŸāļ•āđŒāđāļ§āļĢāđŒāļĒāļļāđ‚āļĢāļ›āļ”āļąāļ™āļ”āļąāļŠāļ™āļĩāđƒāļāļĨāđ‰āļˆāļļāļ”āļŠāļđāļ‡āļŠāļļāļ”āđƒāļŦāļĄāđˆ āļ”āļ­āļĨāļĨāļēāļĢāđŒāļĢāđˆāļ§āļ‡āļĨāđ‰āļēāļ‡āļāļģāđ„āļĢāļ—āļąāđ‰āļ‡āļŠāļąāļ›āļ”āļēāļŦāđŒ

14 āļŠāļīāļ‡āļŦāļēāļ„āļĄ 2026, 16:51

Reddit āļŠāļđāđˆ S&P 500 āļŦāļļāđ‰āļ™āļžāļļāđˆāļ‡ 12% 📈 āļˆāļēāļāđ€āļ§āđ‡āļšāļšāļ­āļĢāđŒāļ”āļŠāļđāđˆ Wall Street

14 āļŠāļīāļ‡āļŦāļēāļ„āļĄ 2026, 08:34

āļ‚āđˆāļēāļ§āđ€āļ”āđˆāļ™āļ§āļąāļ™āļ™āļĩāđ‰ 14 āļŠ.āļ„.

āļœāļĨāļīāļ•āļ āļąāļ“āļ‘āđŒāļ—āļēāļ‡āļāļēāļĢāđ€āļ‡āļīāļ™āļ—āļĩāđˆāđ€āļĢāļēāđƒāļŦāđ‰āļšāļĢāļīāļāļēāļĢāļĄāļĩāļ„āļ§āļēāļĄāđ€āļŠāļĩāđˆāļĒāļ‡ āđ€āļĻāļĐāļŦāļļāđ‰āļ™ (Fractional Shares) āđ€āļ›āđ‡āļ™āļœāļĨāļīāļ•āļ āļąāļ“āļ‘āđŒāļ—āļĩāđˆāđƒāļŦāđ‰āļšāļĢāļīāļāļēāļĢāļˆāļēāļ XTB āđāļŠāļ”āļ‡āļ–āļķāļ‡āļāļēāļĢāđ€āļ›āđ‡āļ™āđ€āļˆāđ‰āļēāļ‚āļ­āļ‡āļŦāļļāđ‰āļ™āļšāļēāļ‡āļŠāđˆāļ§āļ™āļŦāļĢāļ·āļ­ ETF āđ€āļĻāļĐāļŦāļļāđ‰āļ™āđ„āļĄāđˆāđƒāļŠāđˆāļœāļĨāļīāļ•āļ āļąāļ“āļ‘āđŒāļ—āļēāļ‡āļāļēāļĢāđ€āļ‡āļīāļ™āļ­āļīāļŠāļĢāļ° āļŠāļīāļ—āļ˜āļīāļ‚āļ­āļ‡āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ­āļēāļˆāļ–āļđāļāļˆāļģāļāļąāļ”
āļ„āļ§āļēāļĄāļŠāļđāļāđ€āļŠāļĩāļĒāļŠāļēāļĄāļēāļĢāļ–āđ€āļāļīāļ™āļāļ§āđˆāļēāđ€āļ‡āļīāļ™āļ—āļĩāđˆāļāļēāļ